Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for February 13, 2012 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Fed Requires Drug Manufacturers to Report Payments to Physicians
In the wake of drug firm scandals involving issues consumer safety, the federal government is implementing new rules to promote transparency in the study and promotion of pharmaceutical drugs. 
x-small text small text medium text large text


    MAYFIELD HEIGHTS, OH, February 13, 2012 /24-7PressRelease/ -- The U.S. government has found itself playing too reactive of a role in regulating drug companies' controversial research and marketing efforts. Drug firms such as Johnson & Johnson have recently violated federal laws by illegally marketing their products.

In some instances, the government is able to eventually bring these drug manufacturers to justice, but not until their unscrupulous actions have already harmed the public. The Obama Administration has grown tired of playing a game of "catch up" with drug firms and is taking steps toward clamping down on the profit-motivated pharmaceutical industry.

This month, the feds will begin to require pharmaceutical firms to disclose all payments they make to doctors associated with their drug products. Drug companies pay physicians to study, research, consult on and speak about their products, but the financial aspect of this relationship leads physicians to be biased on the value of the drug, whether intentional or subconsciously.

Disclosing the money exchanged between drug companies and doctors creates a new layer of transparency in the drug development process, allowing the government to identify medical studies or promotional efforts that have been tainted by self interest. The reporting requirement may also make doctors more aware of their unintentional or purposeful biases, helping to prevent unsafe drugs from entering the market.

Unfortunately, some medications will inevitably be made available to consumers before their safety and effectiveness are adequately studied. Drugs such as Yaz birth control pills, Reglan, Fosamax and Raptiva have recently put millions of patients at risk of devastating and deadly side effects. The pharmaceutical industry is too big and rich for the government to wholly babysit. Consumer safety is the responsibility of drug firms, but they often make their decisions based on profits -- not on consumer safety.

If you or a loved one is seriously injured or killed by pharmaceutical drugs, you may have the right to recover monetary compensation in a personal injury lawsuit or wrongful death claim. Contact an experienced drug recall lawyer to discuss your and your family's legal options for recovering damages.

6105 Parkland Blvd.
Mayfield Heights, OH 44124
Local: 440-442-6677

Website: http://www.elkandelk.us


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Read more Press Releases from Elk & Elk:

Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Social Media:
Share or bookmark this story using Facebook, Twitter, Digg, and more.

Bookmark and Share
Press Release Contact Information:
Elk & Elk
Elk & Elk

Drug Recall Lawyers
6105 Parkland Blvd.
Mayfield Heights, Ohio
United States 44124
Voice: 440-442-6677
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.